Vaccine News and Research

Latest Vaccine News and Research

mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone

Researchers assessed the chances of COVID-19 hospitalization after three versus two mRNA vaccine doses.

28 Sep 2022

Researchers computationally design immunogens to elicit antibodies against different SARS-CoV-2 variants

A recent study designed immunogens to induce antibodies against SARS-CoV-2 variants.

28 Sep 2022

Food, vaccines, bacteria, and viruses may all prime our immune system to attack SARS-CoV-2

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, primarily causes mild to moderate upper-respiratory tract illness. However, some individuals with COVID-19 develop severe infections and require hospital admission.

27 Sep 2022

New lab technique could spark a 'paradigm shift' in testing protein-based drugs

New Jersey Institute of Technology researchers have unveiled a new lab technique they say represents a "paradigm shift" in how pharmaceutical laboratories test and produce new protein-based drugs, such as therapeutic monoclonal antibodies being developed to treat a variety of diseases, from cancers to infectious diseases.

27 Sep 2022

Natural product SSP derived from a Chinese herb may have broad antiviral activities against respiratory viral infections

A research team comprised of members of the School of Chinese Medicine, AIDS Institute, Department of Microbiology, School of Clinical Medicine and State Key Laboratory for Emerging Infectious Diseases, the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) have discovered a natural product SSP derived from a Chinese herb Spatholobus Suberectus Dunnthat demonstrated broad antiviral activities against SARS-CoV-1, SARS-CoV-2, influenza, and HIV-1 as an entry blocker.

27 Sep 2022

Areas hospitable to Lassa virus spread may extend in the next several decades

In the study, which appeared on September 27 in Nature Communications, scientists analyzed decades of environmental data associated with Lassa virus outbreaks, revealing temperature, rainfall and the presence of pastureland areas as key factors contributing to viral transmission.

27 Sep 2022

What is the vaccine efficacy of repeated influenza vaccinations?

In a new study, researchers calculated the decrease in vaccine effectiveness due to repeated influenza vaccinations.

27 Sep 2022

Association between COVID-19 vaccination and increase in menstrual cycle length confirmed

A large international study has confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day.

27 Sep 2022

Evolution of pathogens during vaccination programs

New research summarized the current understanding of pathogen evolution.

27 Sep 2022

Vaccinating mothers during pregnancy may be an effective strategy to boost COVID antibodies in infants

Women with COVID in pregnancy who are subsequently vaccinated after recovery, but prior to delivery, are more likely to pass antibodies on to the child than similarly infected but unvaccinated mothers are.

27 Sep 2022

Differences in protection from previous infection or vaccination against infection with Omicron BA.4/5 or BA.2

Researchers investigated the differences in vaccination- and previous infection-induced immunities against the Omicron BA.2 and BA.4/5 subvariants of SARS-CoV-2.

27 Sep 2022

New scoring tool helps to 'transparently' prioritize which countries need Covid-19 vaccines the most

A new scoring tool that helps to 'transparently' prioritize which countries are in greatest need of Covid-19 vaccines, has been developed by a UCL-led team of researchers.

27 Sep 2022

First data on Pfizer-BioNTech's Omicron BA.4/5 combination vaccine

In a recent study posted to the bioRxiv* preprint server, researchers from Germany and the United States analyzed the association between exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.4/BA.5 spike glycoprotein and pan-Omicron neutralization.

27 Sep 2022

First real-world study shows the effectiveness of mRNA COVID-19 vaccines during pregnancy

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed by a booster, are effective in protecting against serious disease in expectant mothers whether the shots are administered before or during pregnancy.

27 Sep 2022

Review says dose of approved COVID-19 vaccines based on weak evidence

A recent study posted to the medRxiv* preprint server reviewed early-phase dose-finding trials to examine the study design, safety, and early antibody response data on approved coronavirus disease 2019 (COVID-19) vaccines and gain insights on design improvements for future candidate COVID-19 vaccine clinical trials.

26 Sep 2022

Study looks at boosting with variant-derived COVID vaccine

In a recent study posted to bioRxiv*, researchers at Washington University School of Medicine, St. Louis, demonstrated that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine booster elicits robust germinal center (GC) B cell responses.

26 Sep 2022

Vaccine News and Research

Latest Vaccine News and Research

mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone

Researchers computationally design immunogens to elicit antibodies against different SARS-CoV-2 variants

Food, vaccines, bacteria, and viruses may all prime our immune system to attack SARS-CoV-2

New lab technique could spark a 'paradigm shift' in testing protein-based drugs

Natural product SSP derived from a Chinese herb may have broad antiviral activities against respiratory viral infections

Areas hospitable to Lassa virus spread may extend in the next several decades

What is the vaccine efficacy of repeated influenza vaccinations?

Association between COVID-19 vaccination and increase in menstrual cycle length confirmed

Evolution of pathogens during vaccination programs

Vaccinating mothers during pregnancy may be an effective strategy to boost COVID antibodies in infants

Differences in protection from previous infection or vaccination against infection with Omicron BA.4/5 or BA.2

New scoring tool helps to 'transparently' prioritize which countries need Covid-19 vaccines the most

First data on Pfizer-BioNTech's Omicron BA.4/5 combination vaccine

First real-world study shows the effectiveness of mRNA COVID-19 vaccines during pregnancy

Review says dose of approved COVID-19 vaccines based on weak evidence

Study looks at boosting with variant-derived COVID vaccine

Omicron BA.1 breakthrough infection in vaccinated individuals recall memory B cells to confer immunity

Resistance of Russian Rhinolophus bats containing ACE2-dependent sarbecoviruses to COVID-19 vaccines

Is covid ‘under control’ in the US? Experts say yes

Long-term follow-up of young people with COVID-19 vaccine myocarditis

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in